Suchergebnisse - "Imai, Hisao"

PubPharm (336)

1

Metabolic Tumor Volume as Significant Predictor for Chemotherapy Containing PD-L1 Blocker in Extensive Stage Small Cell Lung Cancer

enthalten in: Anticancer research | 2024

von Hashimoto, K. | Kaira, K. | Imai, H. | +7

2

Real-World Data on Subsequent Therapy for First-Line Osimertinib-Induced Pneumonitis : Safety of EGFR-TKI Rechallenge (Osi-risk Study TORG-TG2101)

enthalten in: Targeted oncology | 2024

von Nishioka, N. | Imai, H. | Endo, M. | +35

3

First-line nivolumab plus ipilimumab with or without chemotherapy for Japanese patients with non-small cell lung cancer : LIGHT-NING study

enthalten in: Japanese journal of clinical oncology | 2024

von Imai, H. | Kijima, T. | Azuma, K. | +18

4

Clinical Outcome of Nivolumab Plus Ipilimumab in Patients with Locally Advanced Non-Small-Cell Lung Cancer with Relapse after Concurrent Chemoradiotherapy followed by Durvalumab

enthalten in: Cancers | 2024

von Mouri, A. | Watanabe, S. | Tokito, T. | +7

5

Efficacy and safety of naldemedine for opioid-induced constipation in older patients with cancer : a retrospective study

enthalten in: European journal of gastroenterology & hepatology | 2024

von Imai, H. | Fujita, Y. | Hiruta, E. | +14

6

Phase II Study of Durvalumab Immediately after Completion of Chemoradiotherapy in Unresectable Stage III Non-small Cell Lung Cancer : TORG1937 (DATE Study)

enthalten in: Clinical cancer research : an official journal of the American Association for Cancer Research | 2024

von Nakamichi, S. | Kubota, K. | Misumi, T. | +17

7

Drastic response of sunitinib after failure of Lenvatinib in patients with previously treated thymic carcinoma

enthalten in: Lung cancer (Amsterdam, Netherlands) | 2024

von Kaira, K. | Imai, H. | Kagamu, H.

8

Small cell lung carcinoma initially presenting as giant left ventricular mass

enthalten in: Japanese journal of clinical oncology | 2024

von Yamaguchi, O. | Kaira, K. | Imai, H. | +1

9

MPO-ANCA positive glomerulonephritis during PD-1 inhibitor combined with anti-CTLA4 antibody in lung cancer

enthalten in: Journal of chemotherapy (Florence, Italy) | 2024

von Kaira, K. | Ikezawa, T. | Inoue, T. | +3

10

Prognostic Potential of the Prognostic Nutritional Index in Non-Small Cell Lung Cancer Patients Receiving Pembrolizumab Combination Therapy with Carboplatin and Paclitaxel/Nab-Paclitaxel

enthalten in: Oncology | 2024

von Nishihara-Kato, F. | Imai, H. | Tsuda, T. | +16

1
2
3
4
5
6
7
8
9
10
11
Nächster »
[34]